Marlborough, CT, United States of America

Jeffrey A Deskus

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.9

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2004-2019

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey A. Deskus

Introduction

Jeffrey A. Deskus is a notable inventor based in Marlborough, CT (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 4 patents to his name, Deskus has focused his research on developing compounds that have the potential to treat various disorders, particularly cancer.

Latest Patents

Among his latest patents, Deskus has developed 5H-pyrido[3,2-B]indole compounds as anticancer agents. This invention is directed to tricyclic compounds of a specific formula, along with pharmaceutically acceptable compositions that comprise these compounds. These compositions are intended for use in methods aimed at treating various disorders, especially cancer. Another significant patent involves tricyclic compounds as anticancer agents, which also includes detailed formulations and methods for their application in treating various disorders.

Career Highlights

Deskus is currently associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work at Bristol-Myers Squibb has allowed him to contribute to the development of innovative therapies that address critical health challenges.

Collaborations

Throughout his career, Deskus has collaborated with several esteemed colleagues, including Ronald J. Mattson and Dalton King. These collaborations have further enhanced the impact of his research and innovations in the pharmaceutical industry.

Conclusion

Jeffrey A. Deskus exemplifies the spirit of innovation in the pharmaceutical field, with his work paving the way for new treatments for cancer and other disorders. His contributions continue to inspire advancements in medical research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…